Simble Solutions Partners with Macquarie University to Advance Nanosensor Technology

Simble Solutions (ASX: SIS) has announced a two-year co-funded research collaboration with Macquarie University to accelerate the development of its exclusive nanosensor technology.

Under the supervision of Macquarie Chief Investigator Professor Noushin Nasiri, the program will focus on initial applications such as e-skin for next-generation soft robotics, UV dosimetry, and health monitoring.

It also has a pathway to expand into sectors like safety monitoring, environmental protection, wearable devices, and infrastructure monitoring.

Simble's contribution includes $288,000 towards project-related costs over the two years, in addition to co-funding graduate costs with Macquarie University.

Platform Integration Plans

A key objective of the collaboration is to integrate the nanosensor technology into Simble's existing SimbleSense and CarbonView platforms.

This strategic move is designed to reduce reliance on third-party hardware.

By bringing proprietary hardware in-house, Simble aims to create cross-selling opportunities within the expanding global IoT sensors market, enhancing its product ecosystem.

While Macquarie University will own any improvements arising from this collaboration, Simble retains exclusive commercialisation rights to these advancements under its existing licence agreement.

Prior Acquisition Strategy

This latest research initiative builds upon Simble's earlier strategic focus on proprietary hardware, with the company entering into a conditional agreement to acquire Next Nano in December 2025.

That proposed acquisition aimed to secure exclusive licence rights to Macquarie University's patented 3D zinc-oxide nanosensor platform, similar to the technology now being advanced.

In its FY25 annual report, Simble highlighted the strategic rationale, noting that third-party devices represented approximately 65% of SimbleSense's cost of sales.

Vertical hardware integration was seen as a way to potentially improve margins.

The proposed Next Nano acquisition was supported by binding commitments for a $2.65 million capital raise, via a two-tranche placement, at $0.005 per share.

Financial Health and Funding Risks

Simble's push into advanced nanosensor technology comes as the company continues to navigate its financial landscape.

The FY25 annual report disclosed an increased net loss after income tax of $1,696,399, and a cash balance at 31 December 2025 of $644,947

The report also flagged a material uncertainty regarding the company's ability to continue as a going concern, citing ongoing losses and liquidity considerations.

Directors noted that continued operations depend on revenue growth, cost management, and securing additional funding.

The company has historically relied on capital raisings to support its operations and strategic initiatives, including the $2.65 million raise linked to the Next Nano acquisition.